一种用于死后中枢神经系统组织CSF1R体外放射自显影的放射性配体
本研究报道了CSF1R高亲和力拮抗剂化合物1的[3H]和[11C]标记合成,并在小鼠、狒狒及死后人脑组织中评估其特性。[11C]1在LPS小鼠神经炎症模型中约50%特异性结合CSF1R,但狒狒PET显示脑摄取低(0.36 SUV);[3H]1在AD患者额叶皮质Bmax显著高于对照。
要点
- 化合物1体外CSF1R结合亲和力高(0.59 nM),[11C]1在小鼠脑内有中等摄取。
- LPS小鼠中[11C]1脑摄取约50%为CSF1R特异性,但狒狒PET脑摄取低(0.36 SUV)。
- [3H]1在AD额叶皮质Bmax显著高于对照(47.78±26.80 vs 12.80±5.30 fmol/mg,P=0.023)。
核心结论
- 化合物1体外CSF1R结合亲和力高;[11C]1在小鼠神经炎症中特异性标记CSF1R,但在狒狒PET中不能有效穿过血脑屏障;[3H]1在死后人脑中特异性标记CSF1R,AD额叶皮质结合显著高于对照。
研究设计与样本
- 研究包括[3H]1和[11C]1的放射合成、小鼠离体脑生物分布、LPS神经炎症小鼠模型、健康雄性Papio anubis狒狒动态PET成像,以及AD和年龄匹配对照死后额叶皮质、顶下皮质和海马的[3H]1饱和结合放射自显影。
主要发现
- 化合物1体外CSF1R结合亲和力为0.59 nM。
- [11C]1在健康小鼠脑内呈中等摄取;在LPS处理小鼠中脑摄取约50%为CSF1R特异性。
- 狒狒PET/CT研究显示[11C]1脑摄取低(0.36 SUV)。
- [3H]1放射自显影显示AD额叶皮质Bmax显著高于对照(47.78 ± 26.80 fmol/mg vs. 12.80 ± 5.30 fmol/mg,P = 0.023)。
- AD海马灰质和顶下皮质白质结合升高但无显著差异。
关键数值与推荐
- 化合物1体外CSF1R结合亲和力0.59 nM。
- LPS处理小鼠脑摄取约50%为CSF1R特异性。
- 狒狒PET/CT中[11C]1脑摄取0.36 SUV。
- AD额叶皮质Bmax 47.78 ± 26.80 fmol/mg vs. 对照12.80 ± 5.30 fmol/mg,P = 0.023。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reactive microglia and recruited peripheral macrophages contribute to the pathogenesis of Alzheimer's dementia (AD). Monocytes, macrophages and microglia all express the marker colony-stimulating factor 1 receptor (CSF1R). 4-Cyano-N-(4-(4-methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)phenyl)-1H-pyrrole-2-carboxamide (1) is a high-affinity antagonist for CSF1R. We report the radiosynthesis of both [3H]1 and [11C]1. The PET imaging properties of [11C]1 in mice and baboon were investigated. [3H]1 was studied in Bmax measurement in post-mortem autoradiography in the frontal cortex, inferior parietal cortex and hippocampus from donors diagnosed with AD and age-matched controls. In vitro binding affinity of 1 was measured commercially. Nor-methyl-1 precursor was radiolabeled with [11C]iodomethane or [3H]iodomethane to produce [11C]1 and [3H]1, respectively. Ex vivo brain biodistribution of [11C]1 was compared in normal mice versus lipopolysaccharide-administered (LPS) murine model of neuroinflammation. Dynamic PET imaging was performed in a healthy male Papio anubis baboon. Post-mortem autoradiography with [3H]1 was performed in frozen sections using a standard saturation binding technique. RESULTS: Compound 1 exhibits a high in vitro CSF1R binding affinity (0.59 nM). [11C]1 was synthesized with high yield. [3H]1 was synthesized similarly (commercially). Biodistribution of [11C]1 in healthy mice demonstrated moderate brain uptake. In LPS-treated mice the brain uptake of [11C]1 was ~ 50% specific for CSF1R. PET/CT [11C]1 study in baboon revealed low brain uptake (0.36 SUV) of [11C]1. Autoradiography with [3H]1 gave significantly elevated Bmax values in AD frontal cortex versus control (47.78 ± 26.80 fmol/mg vs. 12.80 ± 5.30 fmol/mg, respectively, P = 0.023) and elevated, but not significantly different binding in AD hippocampus grey matter and inferior parietal cortex (IPC) white matter. CONCLUSIONS: Compound 1 exhibits a high in vitro CSF1R binding affinity. [11C]1 specifically labels CSF1R in the mouse neuroinflammation, but lacks the ability to efficiently cross the blood-brain barrier in baboon PET. [3H]1 specifically labels CSF1R in post-mortem human brain. The binding of [3H]1 is significantly higher in the post-mortem frontal cortex of AD versus control subjects.
引用
- Foss CA, Naik R, Das D, et al. A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissues. EJNMMI Res. 2024. PMID: 39186197. doi:10.1186/s13550-024-01133-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。